Non Steroidal Anti Inflammatory Drugs - Diclofenac
Generic Name |
diclofenac with or without misoprostol |
Strength |
25 mg, 50 mg; |
Form |
tablet |
Special Authority Criteria |
Approval Period |
1. Diagnosis of rheumatoid or psoriatic arthritis, ankylosing spondylitis, gout or lupus.
OR 2. Treatment failure on optimal dose of, or intolerance to, at least one of the following: ASA-enteric coated, ibuprofen, or naproxen. |
Indefinite |
Practitioner Exemptions
Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Paediatrics
- Paediatric Cardiology
- Paediatric General Surgery
- Physical Medicine and Rehabilitation
- Rheumatology
Special Notes
- Full coverage for diclofenac 75 mg and 100 mg sustained release products is provided only for individuals who have documented breakthrough symptoms while on the regular release form for a trial period at usual adult doses for at least 4 weeks. Full coverage cannot be provided for dosage convenience.
- Topical diclofenac is not eligible for PharmaCare coverage.
- Suppositories are regular benefits and not subject to the RDP.